 |
 |
 |
 |
 |
 |
 |
 |
E-Mail
ShareNew or Experimental Hepatitis C Medications
- Vertex: Telaprevir Could Shorten Hep C Treatment (August 11, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Merck Reports Encouraging Results for Hepatitis C Treatment (August 5, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C Drug Raises Cure Rate in Late Trial (June 7, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - New FDA Hepatitis List Serve (March 12, 2009)
From U.S. Food and Drug Administration - Hepatitis C: New Treatments in the Pipeline (April 2008)
To read PDF, click here.
From Treatment Action Group - Is a New Generation of HCV Treatment Near? (November 2, 2007)
In The New York Times - What's in the Hep C Pipeline? (Fall 2007)
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America - Studying New Drugs for HCV (September 2007)
Excerpts from the FDA hearings.
To read PDF, click here.
In TAGline, from Treatment Action Group - The Sitges Statement on HCV Drug Development (September 2007)
To read PDF, click here.
In TAGline, from Treatment Action Group - Research Into New Drugs to Treat HCV (August 2007)
To read PDF, click here.
In Guide to Hepatitis C for People Living With HIV, from Treatment Action Group - Hepatitis C at CROI: Growing Chasm Between Bench and Bedside (April 2006)
A brief review of research on experimental treatments presented at the 13th Conference on Retroviruses and Opportunistic Infections.
To read PDF, click here.
In TAGline, from Treatment Action Group - The Hepatitis C Treatment Pipeline (Spring 2006)
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America - Vertex's Hepatitis C Drug VX-950 Gets FDA Fast Track (December 9, 2005)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - FDA Approves Hepatitis C Treatment Ribasphere (December 9, 2005)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The Hepatitis C Virus Treatment Pipeline (September 29, 2005)
[Archived Article]
To read PDF, click here.
In TAGline, from Treatment Action Group - Protease Inhibitors for Hepatitis C Treatment: Glimpses of Hope on a Distant Horizon (August 2004)
[Archived Article]
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Proliferation of Polymerase Inhibitors and Other Tales From the HCV Crypt (February 2004)
[Archived Article]
A look at the various drugs in the hepatitis C treatment pipeline.
In TAGline, from Treatment Action Group - Hepatitis C Treatment May Halve Injections (November 6, 2002)
[Archived Article]
Albuferon-alpha may be easier treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Novel Treatments for HCV (October 21, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.